Sprint Bioscience AB (publ)
SSE:SPRINT.ST
0.876 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -0.438 | -60.17 | -25.627 | -37.848 | -20.24 | -22.059 | -10.668 | 4.566 | -15.357 | -11.464 | -4.078 | -3.478 |
| Depreciation & Amortization
| 0.447 | 0.618 | 0.59 | 0.697 | 0.731 | 0.704 | 0.564 | 3.336 | 0.208 | 0.386 | 0.309 | 0.069 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 22.862 | 0.498 | -15.568 | 8.824 | -7.198 | 2.429 | -12.953 | -0.353 | 15.901 | 0.148 | 0.512 | 1.186 |
| Accounts Receivables
| -2.549 | -0.093 | -0.096 | 3.802 | -5.377 | -0.221 | -0.092 | 3.664 | -5.854 | -0.651 | 0.843 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.027 | 0 |
| Accounts Payables
| 2.022 | 0.843 | -0.431 | 0.846 | -2.117 | 1.316 | -0.227 | 1.038 | 1.695 | 0 | 0 | 0 |
| Other Working Capital
| 23.389 | -0.252 | -15.041 | 4.176 | 0.296 | 1.334 | -12.634 | -5.055 | 20.06 | 0.478 | -0.102 | 0 |
| Other Non Cash Items
| 1.421 | 0.486 | 0.488 | -3.896 | -1.296 | -0.157 | 0.005 | 0.386 | 0.081 | 0.17 | -0.309 | -0.069 |
| Operating Cash Flow
| 22.871 | -59.054 | -40.117 | -32.223 | -28.003 | -19.083 | -23.052 | 7.935 | 0.834 | -10.759 | -3.566 | -2.292 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -2.454 | 0 | -2.707 | 0 | -0.093 | -11.076 | -8.564 | -9.909 | -6.189 | -4.049 | -4.288 | -2.638 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | -0.296 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | -0.296 | 0 | -8.36 | -8.738 | -5.376 | -3.917 | -3.848 | 2.246 |
| Investing Cash Flow
| -2.454 | 0 | -2.707 | 0 | -0.389 | -11.076 | -8.564 | -9.909 | -6.189 | -4.049 | -4.288 | -0.392 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 0 | 0 | -10 | -10 | -12 | -12 | -0.769 | -0.769 | -0.769 | -0.192 | -1.998 | 0 |
| Common Stock Issued
| 0.002 | 17.903 | 88.803 | 48.933 | 36.243 | 37.874 | 10.257 | 18.551 | 0 | 28.421 | 6.652 | 2.614 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.024 | 17.903 | 7.59 | 11.985 | -2.161 | 5.497 | 9.488 | 18.55 | -0.769 | -0.192 | 1.803 | 0 |
| Financing Cash Flow
| 0.024 | 17.903 | 86.393 | 50.918 | 22.082 | 43.371 | 9.488 | 17.781 | -0.769 | 28.229 | 8.455 | 2.614 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | -0.001 | 0.09 | 0.172 | -0.224 | -0.048 | -0.02 | 0 |
| Net Change In Cash
| 20.441 | -41.151 | 43.569 | 18.695 | -6.31 | 13.211 | -22.128 | 15.98 | -6.349 | 13.373 | 0.601 | -0.07 |
| Cash At End Of Period
| 49.934 | 29.493 | 70.644 | 27.075 | 8.38 | 14.69 | 1.479 | 23.607 | 7.627 | 13.976 | 0.603 | 0.002 |